HB Biotechnologies Corporation
Research - New York, New York, United States
HB Biotechnologies Corporation Employees
HB Biotechnologies Corporation Senior Management
HB Biotechnologies Corporation Details
HB Biotech provides a transformative approach to fluid management -- representing a true advancement in cardio renal specialty care. The company is commercializing a patented and clinically-proven tool for removing excess fluid from patients with heart failure and chronic kidney disease. Data shows that use of the product results in improvements in blood pressure, weight, edema, endurance, and most consequentially, heart failure classification. Patented in 38 European countries, Canada, and Japan, pending USA. Total addressable market for this low risk solution is in excess of $5 billion. HB Biotech is actively seeking a strategic investment or licensing partner to help bring this treatment to market.
HB Biotechnologies Corporation Technologies
Tag Management
Google Tag Manager
Fonts
Google Font API
Hosting
GoDaddy Hosting
Other
Mobile Friendly